When does most marijuana legitimately leave the track and trace regulatory framework?

The correct answer indicates that most marijuana leaves the track and trace regulatory framework during adult use sales and medical use sales. This is because, at these points, the cannabis is transferred from regulated entities to consumers, effectively concluding the need for stringent tracking as per regulatory requirements.

Track and trace systems are established to ensure that all cannabis products can be accounted for throughout their lifecycle—from cultivation, processing, and testing, until they reach the point of sale. However, once the product has been sold, it is no longer part of the inventory which needs regulatory oversight as it is now in the hands of the consumer.

In this context, other options, while relevant to the cannabis supply chain, do not reflect the point at which regulatory tracking is no longer necessary. During cultivation or when delivered to a store, for instance, the cannabis is still under the purview of the regulatory framework. Similarly, before testing, products are still within the bounds of compliance, as they are awaiting necessary evaluations to ensure safety and quality. Thus, the transition to individual ownership during sales is where the regulatory tracking ceases to apply.